Form 4 for COSM Cosmos Health Inc.
Accepted 2022-12-02 00:00:00 ET · period of report 2022-12-02 · accession 0001477932-22-009026 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-12-02 | 2022-12-02 | COSM | Siokas Grigorios | CEO, Dir, 10% | C - Cnv Deriv | $0.62 | +1.13M | 21.75M | +5% | +$701.3K |
| D | 2022-12-02 | 2022-12-02 | COSM | Siokas Grigorios | CEO, Dir, 10% | C - Cnv Deriv | $0.62 | -703 | 0 | -100% | -$435.86 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $.001 par value | 2022-12-02 | C | A | 1,131,098 | $0.62 | 21,747,605 | D | — | — | (F1) Mr. Siokas acquired these shares upon conversion of 703 shares of Series A Convertible Preferred Stock ("Series A Shares"), $1,000.00 stated value per share, convertible at $0.62152 per share. |
| 2 | Derivative | Series A Preferred Stock | 2022-12-02 | C | D | 703 | $0.62 | 0 | D | $0.62 · 2022-02-28 to — | 0 Common Stock | (F2) Mr. Siokas converted the Series A Shares, as set forth in Note (1), above pursuant to a Conversion Notice dated December 2, 2022 (F3) N/A |